title: Immune responses to new vaccine candidates constructed by a live attenuated Salmonella Typhimurium delivery system expressing Escherichia coli F4, F5, F6, F41 and intimin adhesin antigens in a murine model.
abstract: To construct a novel live oral vaccine candidate for the prevention of pathogenic Escherichia coli infections in neonatal piglets, an expression and secretion plasmid and an attenuated Salmonella delivery system were used. The individual E. coli genes K88ac, K99, FasA, F41 and intimin adhesins were inserted into pBP244 containing asd, lepB, secA and secB, and these plasmids were transformed into a Salmonella Typhimurium ΔcpxR Δlon Δasd. Forty female BALB/c mice were divided into four groups, A to D (ten mice per group). Groups A and B were administered with the mixture containing all constructs and the S. Typhimurium containing pBP244 only as a control, respectively. Groups C and D were primed and boosted with the mixture and the S. Typhimurium harboring pBP244 only, respectively. Each recombinant adhesin secreted from the individual candidates was confirmed by Western blot analysis. The serum IgG and secretory IgA (sIgA) titers to individual adhesins in all immunized groups were higher than those in control. Furthermore, IgG and sIgA levels in group C were higher than those in group A, and the IgG1 titers were increased in Group C but IgG2a titers were similar or decreased in Group C compared to Group A. In addition, the vaccine strains were not detected in fecal samples of any immunized mice. The novel vaccine candidates are not only highly immunogenic, but also safe for vaccinated mice and environment. In addition, the immune responses can be more efficiently induced through the booster-administration.
authors.affiliation: Veterinary Public Health, College of Veterinary Medicine and Bio-Safety Research Institute, Chonbuk National University, Jeonju 561-756, South Korea.
authors.forename: Jin
authors.initials: J
authors.lastname: Hur
authors.forename: John Hwa
authors.initials: JH
authors.lastname: Lee
mesh_terms: D018829:Adhesins, Bacterial / Q000276:immunology; D018830:Adhesins, Escherichia coli / Q000276:immunology*; D000818:Animals; D000942:Antigens, Bacterial / Q000276:immunology; D000954:Antigens, Surface / Q000276:immunology; D001427:Bacterial Toxins / Q000276:immunology; D016503:Drug Delivery Systems; D004927:Escherichia coli Infections / Q000276:immunology / Q000662:veterinary*; D029968:Escherichia coli Proteins / Q000276:immunology; D022361:Escherichia coli Vaccines / Q000008:administration & dosage / Q000276:immunology*; D005260:Female; D036781:Fimbriae Proteins / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D023421:Models, Animal; D012486:Salmonella typhimurium; D013552:Swine; D013553:Swine Diseases / Q000276:immunology*; D014170:Transformation, Genetic; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000276:immunology; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000276:immunology
chemical_list: D018829:Adhesins, Bacterial; D018830:Adhesins, Escherichia coli; D000942:Antigens, Bacterial; D000954:Antigens, Surface; D001427:Bacterial Toxins; D029968:Escherichia coli Proteins; D022361:Escherichia coli Vaccines; C083561:F41 antigen, E coli; C026888:K88 antigen, E coli; C031429:K99 antigen; D014613:Vaccines, Attenuated; D014614:Vaccines, Synthetic; C035391:antigen 987P, E coli; C073819:eaeA protein, E coli; D036781:Fimbriae Proteins